2022 Brief Practice Update on Intravenous Thrombolysis Before Thrombectomy in Patients With Large Vessel Occlusion Acute Ischemic Stroke: A Statement from Society of Vascular and Interventional Neurology Guidelines and Practice Standards (GAPS) Committee

Neuroendovascular management of emergent large vessel occlusion: update on the technical aspects and standards of practice by the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery.

Gandhi CD, et al. J NeuroIntervent Surg 2018;0:1–6. doi:10.1136/neurintsurg-2017-013554 Neuroendovascular management of emergent large vessel occlusion: update on the technical aspects and standards of practice by the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery Chirag D Gandhi, Fawaz Al Mufti, I Paul Singh, Todd Abruzzo, Barbara Albani, Sameer A Ansari, Adam...

Outcome After Thrombectomy and Intravenous Thrombolysis in Patients With Acute Ischemic Stroke: A Prospective Observational Study.

BACKGROUND AND PURPOSE In patients with ischemic stroke, randomized trials showed a better functional outcome after endovascular therapy with new-generation thrombectomy devices compared with medical treatment, including intravenous thrombolysis. However, effects on mortality and the generalizability of results to routine clinical practice are uncertain. METHODS In a prospective observational...

Outcome After Thrombectomy and Intravenous Thrombolysis in Patients With Acute Ischemic Stroke

Endovascular acute ischemic stroke therapy: Society of Vascular and Interventional Neurology roundtable proceedings.

Osama O. Zaidat, MD, MS Dileep R. Yavagal, MD Over 15 years ago, the US Food and Drug Administration (FDA) approved the use of tissue plasminogen activator (tPA) for acute ischemic stroke (AIS) within 3 hours of symptom onset.1 Since then, additional landmark advancements in AIS included the results of the Prolyse in Acute Cerebral Thromboembolism (PROACT) trial and the Middle Cerebral Artery E...

Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke

  Background: Thrombolytic therapy is the only approved treatment for acute cerebral ischemia. The hemorrhagic transformation is the greatest complication of this treatment, which may occur after recanalization of occluded artery. The aim of this study was to determine factors associated with clinical improvement and worsening in patients with acute ischemic stroke treated with intravenous th...